135 related articles for article (PubMed ID: 19461239)
1. Allelotyping, microsatellite instability, and BRAF mutation analyses in common and atypical melanocytic nevi and primary cutaneous melanomas.
Uribe P; Wistuba II; Gonzalez S
Am J Dermatopathol; 2009 Jun; 31(4):354-63. PubMed ID: 19461239
[TBL] [Abstract][Full Text] [Related]
2. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
3. Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma.
Birindelli S; Tragni G; Bartoli C; Ranzani GN; Rilke F; Pierotti MA; Pilotti S
Int J Cancer; 2000 Apr; 86(2):255-61. PubMed ID: 10738254
[TBL] [Abstract][Full Text] [Related]
4. BRAF and NRAS mutations in spitzoid melanocytic lesions.
Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
[TBL] [Abstract][Full Text] [Related]
5. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin.
Uribe P; Wistuba II; González S
Am J Dermatopathol; 2003 Oct; 25(5):365-70. PubMed ID: 14501284
[TBL] [Abstract][Full Text] [Related]
6. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.
Yeh I; von Deimling A; Bastian BC
J Natl Cancer Inst; 2013 Jun; 105(12):917-9. PubMed ID: 23690527
[TBL] [Abstract][Full Text] [Related]
7. High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients.
Masaki T; Wang Y; DiGiovanna JJ; Khan SG; Raffeld M; Beltaifa S; Hornyak TJ; Darling TN; Lee CC; Kraemer KH
Pigment Cell Melanoma Res; 2014 May; 27(3):454-64. PubMed ID: 24483290
[TBL] [Abstract][Full Text] [Related]
8. Genotypic analysis of primary and metastatic cutaneous melanoma.
Rao UN; Jones MW; Finkelstein SD
Cancer Genet Cytogenet; 2003 Jan; 140(1):37-44. PubMed ID: 12550756
[TBL] [Abstract][Full Text] [Related]
9. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus.
Rübben A; Bogdan I; Grussendorf-Conen EI; Burg G; Böni R
Recent Results Cancer Res; 2002; 160():100-10. PubMed ID: 12079204
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract.
Tseng D; Kim J; Warrick A; Nelson D; Pukay M; Beadling C; Heinrich M; Selim MA; Corless CL; Nelson K
J Am Acad Dermatol; 2014 Aug; 71(2):229-36. PubMed ID: 24842760
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi.
Uribe P; Andrade L; Gonzalez S
J Invest Dermatol; 2006 Jan; 126(1):161-6. PubMed ID: 16417232
[TBL] [Abstract][Full Text] [Related]
13. NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.
Tschandl P; Berghoff AS; Preusser M; Burgstaller-Muehlbacher S; Pehamberger H; Okamoto I; Kittler H
PLoS One; 2013; 8(7):e69639. PubMed ID: 23861977
[TBL] [Abstract][Full Text] [Related]
14. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi.
Indsto JO; Cachia AR; Kefford RF; Mann GJ
Clin Cancer Res; 2001 Dec; 7(12):4054-9. PubMed ID: 11751501
[TBL] [Abstract][Full Text] [Related]
15. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
[TBL] [Abstract][Full Text] [Related]
16. Melanocytic nevi and melanoma: unraveling a complex relationship.
Damsky WE; Bosenberg M
Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous topographic profiles of kinetic and cell cycle regulator microsatellites in atypical (dysplastic) melanocytic nevi.
Husain EA; Mein C; Pozo L; Blanes A; Diaz-Cano SJ
Mod Pathol; 2011 Apr; 24(4):471-86. PubMed ID: 21336261
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of loss of heterozygosity and microsatellite instability in adult and pediatric melanoma.
Uribe P; Wistuba II; Solar A; Balestrini C; Perez-Cotapos ML; Gonzalez S
Am J Dermatopathol; 2005 Aug; 27(4):279-85. PubMed ID: 16121045
[TBL] [Abstract][Full Text] [Related]
19. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
Dong J; Phelps RG; Qiao R; Yao S; Benard O; Ronai Z; Aaronson SA
Cancer Res; 2003 Jul; 63(14):3883-5. PubMed ID: 12873977
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.
Akslen LA; Puntervoll H; Bachmann IM; Straume O; Vuhahula E; Kumar R; Molven A
Melanoma Res; 2008 Feb; 18(1):29-35. PubMed ID: 18227705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
